Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
b1fj8B7G7A97z3qA
